US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ERNA Eterna Therapeutics Inc

2.02

0.0535 (2.72%)

21 Jun 2024 - Cerrado

Retrasado por 15 minutos

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
ny20008400x5_ars.pdf

Eterna Therapeutics (NASDAQ:ERNA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Eterna Therapeutics.

Eterna Therapeutics (NASDAQ:ERNA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Eterna Therapeutics.

Noticias sobre Eterna Therapeutics Inc. ERNA

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martes 14 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs i
Viernes 10 de Mayo 2024 (1 mes hace) • GlobeNewswire Inc.

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board
Miércoles 8 de Mayo 2024 (2 meses hace) • GlobeNewswire Inc.

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs i
Martes 7 de Mayo 2024 (2 meses hace) • GlobeNewswire Inc.

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
Martes 20 de Febrero 2024 (4 meses hace) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Viernes 16 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 16 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 31 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Miércoles 24 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Lunes 22 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 19 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Viernes 19 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Más de Eterna Therapeutics Inc. Artículos de Noticias

BNP Paribas (QX)

Financial Select Sector

Gold vs US Dollar

US Dollar vs MXN

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones